ARTICLE | Company News
Metabolex, Yamanouchi deal
March 25, 2002 8:00 AM UTC
Metabolex and Yamanouchi partnered to develop therapeutics to treat Type II diabetes, insulin resistance, impaired glucose tolerance (IGT) and obesity. The partners will screen 100 targets from Metabo...